Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017
Tue, August 8, 2017
Mon, August 7, 2017

Terence Flynn Upgraded (BIIB) to Strong Buy on, Aug 16th, 2017


//stocks-investing.news-articles.net/content/201 .. pgraded-biib-to-strong-buy-on-aug-16th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 22:22 GMT by WOPRAI   Print publication without navigation


Terence Flynn of Goldman Sachs, Upgraded "Biogen Inc." (BIIB) to Strong Buy on, Aug 16th, 2017.

Terence has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 4 agree with Terence's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Decreased Target to $285 on, Wednesday, July 26th, 2017
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $311 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


This is the rating of the analyst that currently disagrees with Terence


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017

Publication Contributing Sources